Literature DB >> 32876798

Association of imaging biomarkers and local activation of complement in aqueous humor of patients with early forms of age-related macular degeneration.

Sascha Fauser1,2, Lebriz Altay3, Vasilena Sitnilska1, Philip Enders1, Claus Cursiefen1.   

Abstract

PURPOSE: To investigate a possible correlation between established imaging biomarkers for age-related macular degeneration and local complement system activation, measured in aqueous humor (AH) of patients with early stages of age-related macular degeneration (AMD) and controls.
METHODS: This analysis included prospectively acquired AH samples of 106 eyes (35 with early/intermediate AMD, 71 controls). The levels of complement protein 3 (C3), 4 (C4), 5 (C5); activation products of complement factor 3a (C3a) and Ba, C3b/iC3b; complement factors B, D, H, I (CFB, CFD, CFH, CFI); and total protein concentration were analyzed. Quantitative levels of complement factors were correlated to the presence of reticular pseudodrusen (RPD), the presence of hyperreflective foci (HRF), and total drusen volume (DV) graded on imaging by spectral-domain optical coherence tomography and using Spearman's rank correlation test.
RESULTS: DV correlated with C3b/iC3b (r = 0.285; P = 0.034), C3a (r = 0.200; P = 0.047), Ba (r = 0.262; P = 0.009), and C5 (r = 430; P = 0.005), and showed a tendency towards correlation with C3a (r = 0.198; P = 0.057). HRF correlated significantly with C5 (r = 0.388; P = 0.011) and RPD showed a tendency towards correlation with CFB (r = 0.196; P = 0.050).
CONCLUSION: In patients with early AMD, HRF and drusen parameters but not RPD show low to fair levels of correlation with local complement activation in patients' AH. Better understanding of complement activation could provide some insights into the pathogenesis of AMD. Imaging biomarkers could be useful to identify suitable patients for future clinical trials with complement-modulating therapies.

Entities:  

Keywords:  Age-related macular degeneration; Aqueous humor; Complement; Imaging biomarkers

Mesh:

Substances:

Year:  2020        PMID: 32876798      PMCID: PMC7904720          DOI: 10.1007/s00417-020-04910-6

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  63 in total

1.  Early local activation of complement in aqueous humour of patients with age-related macular degeneration.

Authors:  L Altay; V Sitnilska; T Schick; G Widmer; G Duchateau-Nguyen; P Piraino; A Jayagopal; F M Drawnel; S Fauser
Journal:  Eye (Lond)       Date:  2019-07-02       Impact factor: 3.775

2.  Documentation of intraretinal retinal pigment epithelium migration via high-speed ultrahigh-resolution optical coherence tomography.

Authors:  Joseph Ho; Andre J Witkin; Jonathan Liu; Yueli Chen; James G Fujimoto; Joel S Schuman; Jay S Duker
Journal:  Ophthalmology       Date:  2010-11-20       Impact factor: 12.079

3.  The epidemiology of retinal reticular drusen.

Authors:  Ronald Klein; Stacy M Meuer; Michael D Knudtson; Sudha K Iyengar; Barbara E K Klein
Journal:  Am J Ophthalmol       Date:  2007-11-28       Impact factor: 5.258

4.  MORPHOLOGICAL AND FUNCTIONAL CHARACTERISTICS AT THE ONSET OF EXUDATIVE CONVERSION IN AGE-RELATED MACULAR DEGENERATION.

Authors:  Xiaofeng Hu; Sebastian M Waldstein; Sophie Klimscha; Amir Sadeghipour; Hrvoje Bogunovic; Bianca S Gerendas; Aaron Osborne; Ursula Schmidt-Erfurth
Journal:  Retina       Date:  2020-06       Impact factor: 4.256

5.  Association between geographic atrophy progression and reticular pseudodrusen in eyes with dry age-related macular degeneration.

Authors:  Marcela Marsiglia; Sucharita Boddu; Srilaxmi Bearelly; Luna Xu; Barry E Breaux; K Bailey Freund; Lawrence A Yannuzzi; R Theodore Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-11-08       Impact factor: 4.799

6.  Local complement activation in aqueous humor in patients with age-related macular degeneration.

Authors:  T Schick; M Steinhauer; A Aslanidis; L Altay; M Karlstetter; T Langmann; M Kirschfink; S Fauser
Journal:  Eye (Lond)       Date:  2017-01-27       Impact factor: 3.775

7.  Clinical classification of age-related macular degeneration.

Authors:  Frederick L Ferris; C P Wilkinson; Alan Bird; Usha Chakravarthy; Emily Chew; Karl Csaky; SriniVas R Sadda
Journal:  Ophthalmology       Date:  2013-01-16       Impact factor: 12.079

8.  Progression of intermediate age-related macular degeneration with proliferation and inner retinal migration of hyperreflective foci.

Authors:  Joseph G Christenbury; Francisco A Folgar; Rachelle V O'Connell; Stephanie J Chiu; Sina Farsiu; Cynthia A Toth
Journal:  Ophthalmology       Date:  2013-01-23       Impact factor: 12.079

9.  Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration.

Authors:  Bert Gold; Joanna E Merriam; Jana Zernant; Lisa S Hancox; Andrew J Taiber; Karen Gehrs; Kevin Cramer; Julia Neel; Julie Bergeron; Gaetano R Barile; R Theodore Smith; Gregory S Hageman; Michael Dean; Rando Allikmets
Journal:  Nat Genet       Date:  2006-03-05       Impact factor: 38.330

Review 10.  Complement inhibition as a therapeutic strategy in retinal disorders.

Authors:  Enoch Kassa; Thomas A Ciulla; Rehan M Hussain; Pravin U Dugel
Journal:  Expert Opin Biol Ther       Date:  2019-02-11       Impact factor: 4.388

View more
  5 in total

1.  Systemic Complement Activation Profiles in Nonexudative Age-Related Macular Degeneration: A Systematic Review.

Authors:  Jonathan B Lin; Stylianos Serghiou; Joan W Miller; Demetrios G Vavvas
Journal:  Ophthalmol Sci       Date:  2022-01-28

2.  Systemic Complement Activation Profiles in Nonexudative Age-Related Macular Degeneration: A Meta-Analysis.

Authors:  Jonathan B Lin; Stylianos Serghiou; Joan W Miller; Demetrios G Vavvas
Journal:  J Clin Med       Date:  2022-04-23       Impact factor: 4.964

3.  Association between inflammatory cytokines in the aqueous humor and hyperreflective foci on optical coherence tomography in patients with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.

Authors:  Jianbo Mao; Nuo Chen; Shian Zhang; Yuyan Fang; Zicheng Zheng; Sulan Wu; Xin Ye; Yijing Chen; Yiqi Chen; Lijun Shen
Journal:  Front Med (Lausanne)       Date:  2022-09-23

4.  Imaging Hyperreflective Foci as an Inflammatory Biomarker after Anti-VEGF Treatment in Neovascular Age-Related Macular Degeneration Patients with Optical Coherence Tomography Angiography.

Authors:  Jing Wu; Chaoyang Zhang; Qian Yang; Hai Xie; Jingting Zhang; Qinghua Qiu; Kun Liu; Dawei Luo; Fang Liu; Jingfa Zhang
Journal:  Biomed Res Int       Date:  2021-02-03       Impact factor: 3.411

Review 5.  The Long Pentraxin PTX3 as a New Biomarker and Pharmacological Target in Age-Related Macular Degeneration and Diabetic Retinopathy.

Authors:  Matteo Stravalaci; Mariantonia Ferrara; Varun Pathak; Francesca Davi; Barbara Bottazzi; Alberto Mantovani; Reinhold J Medina; Mario R Romano; Antonio Inforzato
Journal:  Front Pharmacol       Date:  2022-01-07       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.